Deutsche Bank Ag\ Biogen Inc. Put Options Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $64,032 - $70,582	292 Added 648.89%	337 $78,000
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $64,796 - $101,349	-299 Reduced 86.92%	45 $10,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $37,876 - $47,974	-136 Reduced 28.33%	344 $103,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $23,434 - $27,928	91 Added 23.39%	480 $139,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $101,190 - $143,116	389 New	389 $106,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.